Dinutuximab Biosimilar – Anti-ganglioside GD2 mAb – Research Grade from ProteoGenix; catalogue PX-TA1323; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Dinutuximab is a monoclonal antibody that binds to ganglioside GD2, a tumor-associated antigen highly expressed on neuroblastoma cells and several other cancers. Anti-GD2 antibodies such as Dinutuximab are widely used in research focused on tumor immunology and antibody-mediated immune responses.
This Dinutuximab biosimilar antibody reproduces the target specificity of the reference antibody and is supplied as a research-grade reagent for scientific studies.
Scientists frequently use Dinutuximab antibody to investigate:
Product: Dinutuximab antibody biosimilar
Target: Ganglioside GD2
Antibody type: Monoclonal antibody
Applications: Cancer research and immunotherapy studies
Quality: High purity and consistent production
The price of Dinutuximab antibody depends on the requested quantity and formulation.
Custom quantities available upon request !
For detailed information about Dinutuximab antibody price, researchers can request a quote or order directly online.
Our Dinutuximab biosimilar antibody is produced to support advanced research programs in oncology and immunotherapy.
Benefits include:
Researchers worldwide trust our antibodies for high-quality and reproducible research results.
ProteoGenix catalogue number PX-TA1323. For research use only.
Target: Dinutuximab Biosimilar – Anti-ganglioside GD2 mAb – Research Grade; Clonality: Monoclonal Antibody; Expression system: Mammalian cells; Purity: >85%; Molecular weight: 145kDa; Buffer: PBS buffer PH7.5; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Dinutuximab Biosimilar – Anti-ganglioside GD2 mAb – Research Grade |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
